SCHEMBL4693469

SCHEMBL4693469

COCc1cc(Br)cc(COCC(C)(C)[SiH](C)C)c1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 4/20 0.34
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19022300 0.83 TACR1 (0.37) TACR1IDO1
SCHEMBL722683 0.78 IDO1 (0.49) IDO1
SCHEMBL3587231 0.77 IDO1 (0.50) TACR1IDO1
SCHEMBL481256 0.77 IDO1 (0.42) IDO1
SCHEMBL643942 0.74
SCHEMBL4801258 0.73 IDO1 (0.56) TACR1IDO1
SCHEMBL5442094 0.73 CYP2A6 (0.34) TACR1
SCHEMBL2497155 0.72 CA2 (0.34)
SCHEMBL21493100 0.71 KMT2A (0.31)
SCHEMBL16951081 0.70 TACR1 (0.49) TACR1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1463501-B1 CIS-IMIDAZOLINES AS MDM2 INHIBITORS HOFFMANN LA ROCHE (CH) 2008-06-11 EP disclosed
EP-1463501-A1 CIS-IMIDAZOLINES AS MDM2 INHIBITORS F. Hoffmann-La Roche AG (CH) 2004-10-06 EP disclosed
US-6617346-B1 Inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity HOFFMANN-LA ROCHE INC. 2003-09-09 US disclosed
WO-2003051360-A1 CIS-IMIDAZOLINES AS MDM2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2003-06-26 WO disclosed